Brief: Kura Oncology & Kyowa Kirin Announce Positive KOMZIFTI Combination Data for acute myeloid
08/12/2025 16:21
Dec 8 (Reuters) - Kura Oncology Inc KURA.O: KURA ONCOLOGY INC - TRIPLET COMBINATION FOR KOMZIFTI WITH VENETOCLAX AND AZACITIDINE WELL TOLERATED IN NEWLY DIAGNOSED AND R/R SETTINGS KURA ONCOLOGY INC - REGISTRATIONAL TRIALS OF ZIFTOMENIB IN FRONT-LINE AML ONGOING Source text: ID:nGNX2NGx2h Further company coverage: 4151.T ((Reuters.Briefs@thomsonreuters.com;))